I’m especially excited about Epitomee as an option for patients who struggle with hunger control at specific times of the day-particularly in the evening, which is a common challenge. Many individuals report good appetite control during the day but experience a resurgence of cravings or loss of dietary control in the late afternoon or evening. In these cases, Epitomee may offer satiety support during these high-risk periods, helping patients better adhere to their nutritional plans.

Dr. Angela Golden

Family Nurse Practitioner and former President of the American Association of Nurse Practitioners

Epitomee offers a flexible, safe, and well-tolerated weight management solution suitable for a wide range of patients across different stages of their weight loss journey. It is an outstanding addition to the army of medications and medical devices that we have today.

Professor Srivastava Gitanjali, MD

Medical Director at Vanderbilt University School of Medicine

I see the Epitomee capsule as an important tool in my toolbox due to its promising weight management treatment. Individuals who struggle with portion control or early satiety and have had little success with diet and exercise are good candidates for Epitomee treatment.

Tonya F. Turner

Dietitian at University of South Carolina

Epitomee supports clinically meaningful weight loss and fits seamlessly into a structured lifestyle approach. When combined with the right behavioral tools, it can help people lose weight and maintain their progress for the long term.

Professor Holly Wyatt, MD

University of Alabama at Birmingham

The idea of a capsule that simulates food and causes a feeling of satiety is coming to market. There is a large group of patients who can benefit from this device, which is effective and safe without significant side effects.

Professor Haim Shirin, MD

Shamir Medical Center, Israel

Epitomee capsule is a safe and effective, non-pharmacological option for weight management with broad application in patients with overweight or obesity. Because the Epitomee treatment was found to be safe, without any difference between placebo and epitome groups in overall and in gastrointestinal-related AEs. and well-tolerated, it can be used for a wide variety of patients, even those who might not tolerate other medications or have contraindications for those medications.

Professor Jamy Ard, MD

Wake Forest University School of Medicine

Epitomee is a good addition to our treatment toolbox – the safety, tolerability and efficacy profile make it a good fit for many patient types and for both weight loss and to aid in weight loss maintenance. We see a significant advantage in using Epitomee for individuals starting at a BMI of 25, a category where most anti-obesity medications are still not approved, regardless of whether additional health complications are present.

Professor Emerita Donna Ryan, MD

Pennington Biomedical Research Center

The Epitomee capsule offers a promising non-pharmacological option for overweight people especially for those patients with metabolic syndrome, where managing weight and improving cardiometabolic parameters is essential. Its favorable safety and tolerability profile makes it a practical addition to our treatment approach, with potential benefits in weight reduction, glycemic control, and overall cardiometabolic risk management.

Dr. Moshe Kamar, MD

General Surgeon, Wolfson Medical Center, Israel